Stock Earnings

Question 1

Abeona Therapeutics Inc'in temel mali tabloları nelerdir?

Accepted Answer

Son mali tabloya (Form-10K) göre, Abeona Therapeutics Inc'in toplam varlıkları $108 olup, net loss $-63'dir.

Question 2

ABEO'ün temel finansal oranları nelerdir?

Accepted Answer

Abeona Therapeutics Inc'in cari oranı 1.68, net kâr marjı 0, hisse başına satış $0'dir.

Question 3

Abeona Therapeutics Inc'in geliri segment veya coğrafya bazında nasıl dağılıyor?

Accepted Answer

Abeona Therapeutics Inc largest revenue segment is Gene and Cell Therapies, at a revenue of 3,500,000 in the most earnings release.For geography, United States is the primary market for Abeona Therapeutics Inc, at a revenue of 3,500,000.

Question 4

Abeona Therapeutics Inc kârlı mı?

Accepted Answer

no, son mali tablolara göre Abeona Therapeutics Inc'in net loss $-63'dir.

Question 5

Abeona Therapeutics Inc'in herhangi bir yükümlülüğü var mı?

Accepted Answer

yes, Abeona Therapeutics Inc'in yükümlülüğü 64'dir.

Question 6

Abeona Therapeutics Inc'in tedavüldeki hisse sayısı kaçtır?

Accepted Answer

Abeona Therapeutics Inc'in toplam tedavüldeki hisse sayısı 45.64'dir.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	3	1	3	10
Revenue Growth (YoY)	--	-100%	200%	-67%	-70%	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	41	29	19	17	22	23
Research & Development	33	34	31	28	34	30
Operating Expenses	74	64	51	46	60	58
Other Non Operating Income (Expenses)	-5	0	-8	11	--	--
Pretax Income	72	-63	-54	-39	-84	-84
Income Tax Expense	15	--	--	--	--	--
Net Income	57	-63	-54	-43	-84	-84
Net Income Growth	-210%	17%	26%	-49%	0%	11%
Shares Outstanding (Diluted)	66.64	41.04	21.38	7.86	3.94	3.71
Shares Change (YoY)	30%	92%	172%	99%	6%	85%
EPS (Diluted)	0.85	-1.55	-2.53	-5.53	-21.57	-22.7
EPS Growth	-183%	-39%	-54%	-74%	-5%	-40%
Free Cash Flow	-71	-58	-37	-43	-69	-36
Free Cash Flow Per Share	-1.06	-1.41	-1.73	-5.47	-17.51	-9.7
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	-1,600%	-4,500%	-1,900%	-480%
Profit Margin	0%	0%	-1,800%	-4,300%	-2,800%	-840%
Free Cash Flow Margin	0%	0%	-1,233.33%	-4,300%	-2,300%	-360%
EBITDA	-71	-62	-45	-42	-54	-44
EBITDA Margin	0%	0%	-1,500%	-4,200%	-1,800%	-440%
D&A For EBITDA	3	2	3	3	3	4
EBIT	-74	-64	-48	-45	-57	-48
EBIT Margin	0%	0%	-1,600%	-4,500%	-1,900%	-480%
Effective Tax Rate	20.83%	--	--	--	--	--

Abeona Therapeutics Inc (ABEO) Price

ABEO Stock Price Chart

ABEO Income

Follow-Up Questions